The Effect of Acute Lysine Administration on α-aminoadipic Acid (Sub-study)

PHASE1CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

May 18, 2017

Study Completion Date

May 18, 2017

Conditions
Healthy
Interventions
DRUG

C-13 labeled Lysine

Carbon-13 is a stable naturally occurring heavy isotope of carbon. Inclusion of a 13C label on lysine allows for subsequent differentiation between endogenous and exogenous lysine and 2-AAA for calculation of clearance and excretion of the lysine bolus.

DRUG

Normal saline

Because patients will have multiple blood draws during the course of the study, subjects will have an IV placed to reduce the number of needle sticks. To keep the vein open for blood collections, we will infuse Normal (0.9%) Saline (NS) at a rate of approximately 10ml/hr in order to keep the line open.

Trial Locations (1)

37203

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT03063476 - The Effect of Acute Lysine Administration on α-aminoadipic Acid (Sub-study) | Biotech Hunter | Biotech Hunter